This Thesis describes the synthesis and characterisation of new Group 2 tetrahydroborate, alkoxide and organohydroborate complexes and their uses as catalysts for the living ROP and immortal ring-opening polymerisation (iROP) of &epsilon;- caprolactone and rac-lactide. <strong>Chapter One</strong> introduces cyclic esters and possible mechanistic pathways leading to polyesters by ROP. Living and immortal ROP, including their kinetic characteristics are discussed. An overview of ROP from an industrial perspective is also given. <strong>Chapter Two</strong> describes the synthesis and characterisation of a new series of Group 2 tetrahydroborate complexes supported by a 3-methyl, 5-tert-butyl tris(pyrazolyl)hydroborate ligand. Their activities towards the ROP of &epsilon;-caprolactone are presented. Detailed mechanistic studies using spectroscopic techniques are discussed and a new mechanism is proposed. <strong>Chapter Three</strong> describes the ROP of rac-lactide using the Group 2 tetrahydroborate complexes introduced in Chapter Two, including their mechanistic studies. <strong>Chapter Four</strong> introduces the new immortal ROP using trialkyl borate and organoborane derivatives as chain-transfer agents (CTAs). The immortal ROP of &epsilon;- caprolactone and rac-lactide using Group 2 initiators with trialkyl borates/organoboranes as CTAs from either in situ generation or external addition is discussed. Possible immortal ROP pathways using this new class of CTAs are illustrated. <strong>Chapter Five</strong> details the synthesis and characterisation of a new series of Group 2 organohydroborate complexes. The &epsilon;-caprolactone and rac-lactide ROP activity shown by the complexes presented is discussed and compared with those obtained from the corresponding tetrahydroborate analogues. <strong>Chapter Six</strong> contains experimental details and characterising data for the new complexes reported in this Thesis. <strong>CD Appendix</strong> contains .CIF files for all the new crystallographically-characterised complexes.

No description available.

Primär myelofibros (PMF) är en typ av myeloproliferativ neoplasm (MPN) som leder till en progressiv och irreversibel benmärgsfibros. En somatisk mutation, Jak2V617F, har hittats hos 50 % av patienterna med MPN i hematopoetiska stamceller. Nyligen har man upptäckt grupp 2 av medfödda lymfoida celler (ILC2) som tillhör det medfödda systemet. De är T-cellernas motsvarighet men saknar TCR-receptorn. ILC2 reagerar på IL-33 och producerar Il-13. Under de senaste åren har man upptäckt att dessa två cytokiner är inblandade i PMF. För att undersöka ILC2:s roll i utvecklingen av benmärgsfibros in vivo producerade vi retrovirus som uttrycker Jak2 vildtyp (JAK2_WT) eller Jak2V617F (JAK2_V617F) och transducerade benmärg vildtyp (BM_WT) eller benmärg ILC2KO (BM_ILC2KO). Benmärgen transplanterades till subletalt bestrålade immunbristande möss (NOG). Klinikopatologiska drag som är karakteristiska för sjukdomens första stadier, som förhöjda hemoglobinnivåer, megakaryocythyperplasi och betydande trombocytos, uppstod inte under studieperioden. Ökade vita blodkroppar uppstod dock på grund av avsaknaden av ILC2 i JAK2_V617F-expressiva möss. Flödescytometeranalys visade ursprunget till den markerade leukocytosen som ett resultat av expansionen från lymfocytlinjen, mer specifikt B-celler, men resultaten är inte entydiga eftersom de förhöjda nivåerna av B-celler kan vara en följd av ILC2 knock-out fenotypen som förvärras av närvaron av mutationen. Granulocytnivåerna från de inympade cellerna hölls låga till följd av att stamcellerna i värdens benmärg var inblandade på grund av subletal bestrålning. Vi drar slutsatsen att frånvaron av ILC2 i JAK2_V617F-uttryckta benmärgsprogenitorer har en tendens att förvärra den myeloproliferativa fenotypen i sjukdomens tidiga skeden, vilket tyder på en möjlig skyddande roll för ILC2 vid utvecklingen av MPN. / Primary myelofibrosis (PMF) is one type of myeloproliferative neoplasm (MPN) that leads to a progressive and irreversible bone marrow fibrosis. A somatic mutation, Jak2V617F has been found in 50% of patients with MPN in hematopoietic stem cells. Group 2 innate lymphoid cells (ILC2) belonging to the innate system has been recently discovered. They are the counter part of T cells but lacking the TCR receptor. ILC2 response to IL-33 producing Il-13. In recent years, the involvement of these two cytokines in the PMF has been uncovered. To investigate the role of ILC2 in the progression of bone marrow fibrosis in vivo we produced retrovirus expressing Jak2 wild-type (JAK2_WT) or Jak2V617F (JAK2_V617F) and transduced bone marrow wild type (BM_WT) or bone marrow ILC2KO (BM_ILC2KO). The bone marrow was transplanted into sub-lethally irradiated immunodeficient mice (NOG). Clinicopathologic features characteristic from the first stages of the disease, as elevated hemoglobin levels, megakaryocyte hyperplasia and significant thrombocytosis did not emerge during the study period. However, increased in white blood cells arise from the absence of ILC2 in JAK2_V617F expressing mice. Flow cytometer analysis revealed the origin of the marked leukocytosis as a result of the expansion from the lymphocyte lineage, more specifically B cells, but the results are inconclusive as the elevated levels of B-cells could be a consequence of the ILC2 knock-out phenotype aggravated by the presence of the mutation. Granulocyte levels from engrafted cells were kept low because of the involvement of host bone marrow stem cells due to sublethal irradiation. We conclude that the absence of ILC2 in JAK2_V617F-express bone marrow progenitors has a tendency to aggravate the myeloproliferative phenotype in the early stages of the disease, indicating a possible protective role of ILC2 in the development of MPNs.

Introduction: Atopic dermatitis (AD) is characterized by chronic pruritic relapsing eczematous lesions of the skin. Eosinophilic inflammation in AD is driven by activation of type 2 inflammatory cells including CD4+ T cells and type 2 innate lymphoid cells (ILC2s). We have shown that type 2 cytokines, namely interleukin (IL)-5 and IL-13, stimulate migration and terminal differentiation of eosinophil progenitor cells (EoPs). We propose that these cytokines are important drivers of tissue eosinophilia in AD lesional skin. This study aimed to quantify, by flow cytometry, cells that produce type 2 cytokines in lesional skin compared to peripheral blood from moderate-severe AD patients. Methods: In a cross-sectional study of patients with moderate-to-severe AD (n=16), type 2 inflammatory cells were enumerated in blood and cells extracted from excised skin biopsies. By flow cytometry, live, singlet CD45+cells were identified as ILC2 (lin-CD127+CD294+), EoP (CD34+125+), and CD4+ T cells (Lin+CD3+CD4+). Intracellular expression of type 2 cytokines (IL-5 and IL-13) were evaluated in each cell population. In addition, we developed a protocol to enumerate ILC2s by fluorescence immune-histochemistry in lesional versus non-lesional skin samples and skin biopsies taken 24h post-intradermal challenge with allergen versus diluent. Data are expressed as median (interquartile range [IQR]) unless otherwise stated. Cross compartmental comparisons were made using the Wilcoxon rank-sum test and where applicable, correlational analyses were performed using a Spearman’s rank-correlational test. Results: There was a significantly higher number of total ILC2s in lesional skin compared to blood from AD subjects (556 [99 – 5501] vs 235 [67 – 569] cells/mL, p=0.03). Similarly, IL-5+, IL-13+ ILC2s, were significantly greater in skin compared to blood (6 [1 – 666] vs 1 [1 – 19] cells/mL, p=0.03; 28 [1 – 1357] vs 1 [1 – 7] cells/mL, p=0.01, respectively). We found higher numbers of total and type 2 cytokine positive EoP in lesional skin biopsies from AD patients compared to blood (Total EoP: 815 [285 – 2794] vs 112 [46 – 247] cells/mL, p<0.01; IL-5+EoP: 36 [1 – 129] vs 1 [1 – 23] cells/mL, p=0.07; IL-13+EoP: 92 [10 – 182] vs 1 [1 – 8] cells/mL, p<0.01 and IL-5+IL-13+ILC2: 70 [1 – 158] vs 1 [1 – 12] cells/mL, p=0.02, respectively). In contrast, significantly higher numbers of total and type 2 cytokine positive CD4+ cells were found in blood compared to lesional skin biopsies from AD patients (Total CD4+: 1092 [650 – 1742] vs 58.3 [35.3– 152.4] x 103 cells/mL, p<0.01 and IL-5+IL-13+CD4+ cells: 13.5 x 103 [2.1 x 103 – 42.9 x 103] vs 3.8 x 103 [1.6 x 103 – 4.9 x 103] cells/mL, p=0.02, respectively). For IF staining, there was a significant higher number of ILC2s in lesional compared to non-lesional skin biopsies and biopsies taken 24h post allergen- compared to diluent challenge (1 [0 – 2] vs 0 [0 - 0] cells/mm2, p=0.008, and 2 [1 – 2] vs 0 [0 – 0] cells/mm2, p=0.0002, respectively). Interestingly, in sex analyses we found significantly greater levels of blood ILC2 in females compared to males, but this not was found in the skin. Importantly, we found a significant correlation between lesional skin levels of ILC2 measured by flow cytometry and clinical measures of disease severity/symptoms as reported/calculated from the Patient-Oriented Eczema Measure questionnaire (POEM) score (total ILC2: r=0.55, p=0.04; IL-13+ ILC2s, r=0.61, p=0.02 and IL-5+ IL-13+ ILC2s: r=0.75, p=0.002). Conclusions: Preferential increases in skin-resident ILC2 that produce a type 2 rich environment were found in AD subjects. These levels correlated with patient-oriented measure of disease severity. We propose that this increase may encourage recruitment of mature eosinophils and EoP and possibly drive localized differentiation of EoP into mature eosinophils that may drive the pathology of AD lesions. Furthermore, immunofluorescence staining may be a suitable alternative to flow cytometry for identification of ILC2 in the event of a low cell count. These techniques can be used in future studies that target ILC2 biology to fully understand the role of these cells in driving AD. / Thesis / Master of Science (MSc)

Throughout many parts of the world house dust mites (HDM) are considered as a major source of indoor aeroallergens and they are powerful inducers of allergic diseases. Proteolytic HDM allergens are recognised as being able to directly activate respiratory epithelial cells and thereby actively participate in innate immune responses. Although several major HDM allergens lack proteolytic activity, their possible ability to similarly interact with epithelial cells is not known. The overall aim of this thesis was therefore to elucidate if and how major non-proteolytic group 2 allergens from different mite species interact with respiratory epithelial cells. The effects of the structurally related Der p 2, Der f 2 and Eur m 2 from different HDM species as well as the storage mite allergen Lep d 2 were studied in vitro using human respiratory epithelial cells. Also the non-proteolytic, but structurally dissimilar, Fel d 1 from cat, Can f 2 from dog, Bet v 1 from birch and Phl p 5a from timothy were studied. In this thesis evidence that major group 2 mite allergens activate bronchial epithelial cells is presented. Following allergen exposure the secreted amount of the inflammatory mediators G-CSF, GM-CSF, IL-6, IL-8, MCP-1, MIP-3α and sICAM-1 was increased. Surface expression of ICAM-1 was also increased following allergen exposure. Moreover, Fel d 1 and Can f 2 induced secretion of the same mediators from bronchial epithelial cells, representing two additional protein structures being able to directly induce cell activation. In experiments using specific inhibitors and siRNA transfection, it was shown that the mite allergens engage TLR4 and activation through MyD88, MAPK and NF-κB signal transduction pathways. In conclusion, the novel findings in this thesis provide knowledge on how major aeroallergens, in addition to their ability to provoke specific adaptive immune responses, may aggravate a respiratory airway disease by adjuvant-like activation of inflammatory responses in bronchial epithelial cells. This differs from previously reported allergen-induction of epithelial cells by the clear independency of proteolytic activation.

The expression of polysaccharide capsules is common in bacteria and associated with virulence in some pathogenic strains. Strains of the Gram-negative bacterium Escherichia coli express a structurally diverse range of capsular polysaccharides. E. coli strains expressing group 2 capsules are associated with a number of extra-intestinal infections, including sepsis, urinary tract infections, and neonatal meningitis. Group 2 capsular polysaccharides are synthesised on the cytoplasmic face of the inner membrane. Evidence from previous work suggests that export of polysaccharides across the Gram-negative membranes involves four transport proteins which interact to form a continuous membrane-spanning translocation complex (the KpsMTED translocon). Polysaccharide translocation across the inner membrane requires the ABC transporter KpsMT, in which KpsM is the integral inner membrane component and KpsT is the ATPase. Transport across the periplasmic space and outer membrane involves the integral inner membrane protein KpsE and the outer membrane protein KpsD, respectively. This thesis addressed some of the key areas in the study of group 2 polysaccharide transport by employing the K5 capsule as a model system. Using biochemical and molecular genetics approaches, the study focused on establishing functional and structural characteristics of the translocon members and analysing protein-protein interactions within the complex. This study demonstrated that KpsE can self-associate as dimers, tetramers and possibly higher order oligomers in the absence of other capsule gene products and the K5 substrate. A mutagenesis study of KpsE revealed that the periplasmic, membrane-associated C-terminus is essential for correct protein function. Work presented here confirmed previous data, which suggested a direct interaction between KpsE and KpsM, by alternative methods, and demonstrated that the C-terminal domain of KpsE is required for this interaction. Further experiments suggested that KpsE and KpsM can both form higher order oligomers when interacting as a complex. The C-terminus of KpsE is not required for an interaction between KpsE and KpsD, and the two proteins are thus more likely to interact via their respective periplasmic domains. Generation of a theoretical model of the secondary structure and topology of KpsD predicted that KpsD is made primarily of β-sheets with some interspersed α-helices, including a larger coiled coil region. The theoretical topology model proposed an N-terminal transmembrane domain made of eight membrane-spanning regions, and a large periplasmic domain. Substituted-cysteine accessibility method and myc-epitope insertion analysis were both assessed for their suitability for topology analysis of KpsD. Myc-epitope insertion was identified as the recommended approach for future topology study. Myc-epitope tagging of the periplasmic C-terminus of KpsD revealed that a native C-terminus is essential for correct KpsD function.In conclusion, this thesis contributes to the model of group 2 polysaccharide export in E. coli, and, more generally, provides clues about the transport of high-molecular weight molecules across Gram-negative membranes. It is hoped that a thorough understanding of polysaccharide transport might reveal therapeutic targets to block capsule export in pathogenic E. coli in the future.

Several hydrides of Group 2 and 12 elements were generated in the gas phase using an emission source that combines an electrical discharge with a high temperature furnace, and their high-resolution infrared emission spectra were recorded with a Fourier transform spectrometer. Two classes of molecules were studied: <em>a)</em> diatomic metal hydrides BeH, MgH, CaH, SrH, ZnH and CdH; <em>b)</em> linear triatomic metal hydrides BeH₂, MgH₂, ZnH₂ and HgH₂. <br /><br /> Infrared emission spectra of BeH, MgH, CaH, SrH, ZnH and CdH free radicals contained several vibration-rotation bands in their ²SIGMA⁺ ground electronic state. The new data were combined with all the previous ground state data from diode laser infrared spectra and pure rotation spectra available in the literature. Spectroscopic constants, i. e. , vibrational band origins, rotational, centrifugal distortion, and spin-rotation interaction constants, were determined for each observed vibrational level by least-squares fitting of all the data. In addition, the data from all isotopologues were fitted simultaneously using the empirical Dunham-type energy level expression for ²SIGMA⁺ states, and correction parameters due to the breakdown of the Born-Oppenheimer approximation were determined. The equilibrium internuclear distances (<em>r</em>_e) of ⁹BeH, ²⁴MgH, ⁴⁰CaH, ⁸⁸SrH, ⁶⁴ZnH and ¹¹⁴CdH were determined to be 1. 342424(2), 1. 729721(1), 2. 002360(1), 2. 146057(1), 1. 593478(2) and 1. 760098(3) angstroms, respectively, and the corresponding <em>r</em>^e distances for ⁹BeD, ²⁴MgD, ⁴⁰CaD, ⁸⁸SrD, ⁶⁴ZnD and ¹¹⁴CdD are 1. 341731(2), 1. 729157(1), 2. 001462(1), 2. 145073(1), 1. 593001(2) and 1. 759695(2) angstroms, respectively. <br /><br /> Gaseous BeH², MgH², ZnH² and HgH² molecules were discovered and unambiguously identified by their high-resolution infrared emission spectra. The &nu;₃ antisymmetric stretching fundamental band and several hot bands in the &nu;₃ region were rotationally analyzed, and spectroscopic constants were obtained for almost all naturally-occurring isotopologues. The rotational constants of the 000 ground states were used to determine the <em>r</em>₀ internuclear distances. For BeH₂, ZnH₂, ZnD₂, HgH₂ and HgD₂ molecules, the rotational constants of the 000, 100, 01¹0 and 001 levels were used to determine the equilibrium rotational constants (<em>B</em>_e) and the associated equilibrium internuclear distances <em>r</em>_e. The <em>r</em>_e distances of ZnH₂ and ZnD₂ differed by about 0. 01%, and those of HgH₂ and HgD₂ differed by about 0. 005%. These discrepancies were larger than the statistical uncertainties by one order of magnitude, and were attributed to the breakdown of the Born-Oppenheimer approximation.

Several hydrides of Group 2 and 12 elements were generated in the gas phase using an emission source that combines an electrical discharge with a high temperature furnace, and their high-resolution infrared emission spectra were recorded with a Fourier transform spectrometer. Two classes of molecules were studied: <em>a)</em> diatomic metal hydrides BeH, MgH, CaH, SrH, ZnH and CdH; <em>b)</em> linear triatomic metal hydrides BeH₂, MgH₂, ZnH₂ and HgH₂. <br /><br /> Infrared emission spectra of BeH, MgH, CaH, SrH, ZnH and CdH free radicals contained several vibration-rotation bands in their ²SIGMA⁺ ground electronic state. The new data were combined with all the previous ground state data from diode laser infrared spectra and pure rotation spectra available in the literature. Spectroscopic constants, i. e. , vibrational band origins, rotational, centrifugal distortion, and spin-rotation interaction constants, were determined for each observed vibrational level by least-squares fitting of all the data. In addition, the data from all isotopologues were fitted simultaneously using the empirical Dunham-type energy level expression for ²SIGMA⁺ states, and correction parameters due to the breakdown of the Born-Oppenheimer approximation were determined. The equilibrium internuclear distances (<em>r</em>_e) of ⁹BeH, ²⁴MgH, ⁴⁰CaH, ⁸⁸SrH, ⁶⁴ZnH and ¹¹⁴CdH were determined to be 1. 342424(2), 1. 729721(1), 2. 002360(1), 2. 146057(1), 1. 593478(2) and 1. 760098(3) angstroms, respectively, and the corresponding <em>r</em>^e distances for ⁹BeD, ²⁴MgD, ⁴⁰CaD, ⁸⁸SrD, ⁶⁴ZnD and ¹¹⁴CdD are 1. 341731(2), 1. 729157(1), 2. 001462(1), 2. 145073(1), 1. 593001(2) and 1. 759695(2) angstroms, respectively. <br /><br /> Gaseous BeH², MgH², ZnH² and HgH² molecules were discovered and unambiguously identified by their high-resolution infrared emission spectra. The &nu;₃ antisymmetric stretching fundamental band and several hot bands in the &nu;₃ region were rotationally analyzed, and spectroscopic constants were obtained for almost all naturally-occurring isotopologues. The rotational constants of the 000 ground states were used to determine the <em>r</em>₀ internuclear distances. For BeH₂, ZnH₂, ZnD₂, HgH₂ and HgD₂ molecules, the rotational constants of the 000, 100, 01¹0 and 001 levels were used to determine the equilibrium rotational constants (<em>B</em>_e) and the associated equilibrium internuclear distances <em>r</em>_e. The <em>r</em>_e distances of ZnH₂ and ZnD₂ differed by about 0. 01%, and those of HgH₂ and HgD₂ differed by about 0. 005%. These discrepancies were larger than the statistical uncertainties by one order of magnitude, and were attributed to the breakdown of the Born-Oppenheimer approximation.

La réponse tissulaire des patients soumis à une radiothérapie, malgré des protocoles de traitement identiques, est variable avec des extrêmes importants. Une des questions posées à la radiobiologie est d'expliquer ces variations (approche a posteriori) et si possible de les prévoir (approche a priori). La réponse d'un organisme et de tissus complexes à la radiothérapie est la résultante de nombreux déterminants. Certains appartiennent à la dynamique et à l'homéostasie tissulaire (inflammation, cytokines, etc.) d'autre à la sensibilité et à la réponse cellulaire (sensibilité intrinsèque, réparation de l'ADN, régulation de la mort cellulaire, etc.). Concernant les déterminants cellulaires, l'Equipe d'Accueil a proposé de classer les humains en 3 groupes de radiosensibilités différentes, le premier considéré comme normal est de loin le plus important (près de 75% des individus), le groupe II de radiosensibilité intermédiaire représente la majeure partie des individus pour lesquels une réponse anormale est constatée après radiothérapie. Le groupe III rassemble des pathologies particulièrement rares associées à une hyper-radiosensibilité marquée, voire très marquée. Les patients du groupe II présentent donc une réponse thérapeutique inattendue et / ou des effets secondaires précoces ou tardifs sévères à des doses d'irradiation dont on attend une tolérance normale. Les patients du groupe II peuvent aussi être caractérisés par une forte prédisposition au cancer et aux tumeurs radio induites. Il existe une variabilité intrinsèque liée à des facteurs endogènes tels que la qualité de réparation de l'ADN, ou la production spontanée de micronoyaux ; et des facteurs exogènes. A cet égard, certaines médications sont susceptibles de modifier la réponse cellulaire à la radiothérapie, telles que les statines, les anticoagulants ou les antiagrégants plaquettaires. Approche a posteriori : par une étude clinique unicentrique de 65 patients atteints de cancers de la prostate et traités par le même radiothérapeute dans les mêmes conditions, la fréquence et la gravité des effets secondaires rectaux par rapport à la prise ou non de statines ont été étudiées : un effet radioprotecteur des statines vis-à-vis de la rectite radique a été mis en évidence in vivo sur des arguments statistiques pertinents. Approche a priori : par l'étude de la réponse cellulaire et moléculaire aux radiations de fibroblastes humains (notamment issus de tissus intestinaux sains). Ont été étudiés : la réparation et la signalisation des cassures double-brin de l'ADN par l'analyse des foci nucléaires H2AX et pATM ; le transit radioinduit de la protéine ATM du cytoplasme vers le noyau a été observé pour la première fois sur des fibroblastes humains rectaux. Les statines semblent accélérer ce transit, produisant un effet modérateur de la sévérité des rectites. L’étude des différents produits antioxydants et stimulateurs de la réparation de l’ADN a permis de montrer que les statines ont effet non équivoqué sur la réparation cellulaire après irradiation. Ces résultats ouvrent des perspectives pour des études plus approfondies de l'usage de médications facilement accessibles capables de moduler la gravité des effets secondaires de la radiothérapie. / The tissue response of patients undergoing radiotherapy, despite identical treatment protocols, could have important variations. One of the questions asked to the radiobiology is to explain these variations (a posteriori approach) and if possible to predict it (a priori approach). The response of an organism and complex tissues to radiotherapy is the result of many determinants. Some belong to the tissue dynamics and homeostasis (inflammation, cytokines, etc.) and others to the sensitivity and cellular response (intrinsic sensitivity, DNA repair, regulation of cell death, etc.). About cellular determinants, our research team proposed to classify humans into three groups of different radiosensitivity levels, the first considered as normal is by far the largest (almost 75% of individuals), group II of intermediate radiosensitivity represents the majority of individuals having an abnormal response to radiotherapy. Group III gathers extremely rare conditions associated with marked or very marked hyper-radiosensitivity which are usually life threatening. Therefore patients in group II show either unexpected therapeutic response or severe radiation early or late side effects after doses for which normal tolerance is expected. Patients in group II can also be characterized by a strong predisposition to cancer and radiation-induced tumors. There is an inherent variability related to endogenous factors, such as the quality of DNA repair, or the spontaneous production of micronuclei; and exogenous factors. In this regard, certain medications may alter the cellular response to radiation therapy, such as statins, antiplatelet agents or anticoagulants. A posteriori approach: a single-center clinical study of 68 patients with prostate cancer treated by the same radiation oncologist in the same conditions, the frequency and severity of rectal side effects are compared to the use or not of statins : a radioprotective effect of statins toward radiation proctitis cannot be excluded. A priori approach: by studying the cellular and molecular radiation response in human fibroblasts (especially from healthy bowel tissue). Were studied: signaling and repair of DNA double-strand breaks by analysis of nuclear foci of MRE11; H2AX and pATM; radiation induced ATM protein transit from the cytoplasm to the nucleus was observed for the first time in rectal tissue fibroblasts. Statins appear to speed up this transit, making possible a radioprotective effect. These results open perspectives for further studies for the use of medications readily available that can modulate the severity of side effects of radiotherapy.

Thesis (M.Sc. (Geology)) -- University of Limpopo, 2022 / The Two Rivers Platinum Mine (TRP) located in the Eastern Bushveld Igneous Complex is currently exploiting platinum-group elements (PGE) in the Upper Group 2 chromitite (UG2) Reef at the Dwarsrivier Farm. TRP has acquired a new prospect (at the Buffelshoek Farm) and is currently planning to mine the UG2 Reef and potentially also the Merensky Reef (MR). Three drill-cores which intersected the UG2 Reef and MR at the Buffelshoek Farm made available by TRP were sampled for mineralogical studies using complementary techniques including reflected light microscopy, mineral liberation analyser and electron microprobe. The platinum group minerals (PGM) which host the PGE exhibit variability in their flotation rates and consequently variable PGE recoveries that is mostly attributed to the not so well understood PGM distributions and characteristics. The purpose of the study was to investigate the PGE process mineralogical characteristics such as the PGM phases, their modal abundances and mineral associations, as well as the grain size distributions within the UG2 Reef and MR at the Buffelshoek Farm. The observed PGM phases are broadly grouped into PGE sulphides, PGE arsenides, PGE bismuth-tellurides, PGE antimonides and PGE alloys. The PGM phases are largely dominated by PGE-sulphides (average of 80%) in the UG2 Reef and PGE-arsenides (average of 39%) in the MR. Although the UG2 Reef and MR are mineralogically different, the PGM observed are similar in composition, but vary in their proportions. The PGM are mostly associated with base metal sulphides typically, pentlandite in the UG2 Reef and silicates, which are dominated by amphiboles in the MR. The PGM grain sizes generally range between 2 and 22 microns in the UG2 Reef and range between 2 and 32 microns in the MR. The concentrations of platinum are the highest in both the UG2 Reef and MR, and with the platinum largely deported in PGE-sulphides (about 69 - 84.9%) in the UG2 Reef and PGE-arsenides in the MR. Palladium is mostly deported in the PGE sulphides (about 52.3 - 69.2%) in the UG2 Reef and mostly deported in PGE antimonides (about 43%) and PGE bismuth-tellurides (about 37%) in the MR. Rhodium (Rh) is entirely deported in the PGE sulphides in the UG2 Reef and deported in PGE sulphides (about 86.5%) and PGE bismuth-tellurides (about 13.5%) in the MR. Expected recoveries of PGM ranges from 76 to 89% for PGE sulphides and arsenides in the UG2 Reef and 61.3% in the MR, which is considered good. PGE bismuth-tellurides, PGE antimonides and PGE alloys are expected to be variably to poorly recovered, requiring suitable reagents to be well recovered both in the UG2 Reef and MR. / Faculty of Science and Agriculture Research Division Geological Society of South Africa North West University's School of Geo- and Spatial Science